Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BSX

Boston Scientific Corp

Sep 15 • 03:25PM ET

100.43

-2.28 -2.22 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV VHT IHI IVW IWD

Scroll to Statements

Index	S&P 500	P/E	59.77	EPS (ttm)	1.68	Insider Own	0.62%	Shs Outstand	1.48B	Perf Week	-7.13%
Market Cap	148.80B	Forward P/E	29.52	EPS next Y	3.40	Insider Trans	-7.68%	Shs Float	1.48B	Perf Month	-3.58%
Enterprise Value	160.42B	PEG	3.93	EPS next Q	0.72	Inst Own	92.70%	Short Float	1.29%	Perf Quarter	0.69%
Income	2.51B	P/S	8.05	EPS this Y	18.83%	Inst Trans	0.70%	Short Ratio	2.67	Perf Half Y	3.36%
Sales	18.49B	P/B	6.63	EPS next Y	14.06%	ROA	6.37%	Short Interest	18.99M	Perf YTD	12.43%
Book/sh	15.14	P/C	231.42	EPS next 5Y	15.20%	ROE	11.71%	52W High	109.50 -8.29%	Perf Year	21.08%
Cash/sh	0.43	P/FCF	42.70	EPS past 3/5Y	21.99% -17.84%	ROIC	7.38%	52W Low	80.64 24.53%	Perf 3Y	135.13%
Dividend Est.	-	EV/EBITDA	36.48	Sales past 3/5Y	12.10% 9.30%	Gross Margin	61.90%	Volatility	2.30% 1.76%	Perf 5Y	145.42%
Dividend TTM	-	EV/Sales	8.67	EPS Y/Y TTM	36.19%	Oper. Margin	16.66%	ATR (14)	2.04	Perf 10Y	518.38%
Dividend Ex-Date	-	Quick Ratio	0.82	Sales Y/Y TTM	21.45%	Profit Margin	13.55%	RSI (14)	32.62	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	1.37	EPS Q/Q	144.43%	SMA20	-4.83%	Beta	0.63	Target Price	125.70
Payout	0.00%	Debt/Eq	0.54	Sales Q/Q	22.84%	SMA50	-4.14%	Rel Volume	1.09	Prev Close	102.71
Employees	53000	LT Debt/Eq	0.52	Earnings	Jul 23 BMO	SMA200	-0.16%	Avg Volume	7.12M	Price	100.43
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.38% 3.43%	Trades		Volume	7,093,483	Change	-2.22%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51

Show Previous Ratings

Today 09:40AM	Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? (Zacks)
09:03AM	Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech (Insider Monkey)
Sep-12-25 07:17AM	Puzzling: Farapulse trial investigator on the devices use beyond recommendations (Medical Device Network)
Sep-11-25 05:18AM	Elutia to divest bioenvelopes business to Boston Scientific for $88m (Medical Device Network)
Sep-10-25 06:00PM	Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know (StockStory)
06:00PM	Loading…
06:00PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
12:35PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
06:20AM	Boston Scientific inks $88M Elutia deal to challenge Medtronic (MedTech Dive)
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
Sep-08-25 12:50PM	Oppenheimer sees stronger growth at Boston Scientific (Investing.com)
12:36PM	Cardinal Health Expands At-Home Solutions With New Texas Facility (Zacks)
09:49AM	Alphabet downgraded, Boeing upgraded: Wall Street's top analyst calls (The Fly)
08:07AM	GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System (Zacks)
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
08:06AM	Here's Why You Should Hold Cencora Stock in Your Portfolio Now (Zacks)
02:20PM	Loading…
Sep-04-25 02:20PM	Healthcare Stocks Are Just Starting Their Resurgence. Hold On to Them. (Barrons.com)
11:40AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
06:00AM	Kardium receives FDA OK for pulsed field ablation system (MedTech Dive)
Sep-03-25 01:23PM	HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
09:30AM	Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
08:50AM	STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep (Zacks)
04:35AM	Is Boston Scientific Stock Outperforming the S&P 500? (Barchart)
Sep-02-25 06:00PM	Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
08:00AM	Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results (PR Newswire)
Sep-01-25 12:53PM	GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System (Zacks)
Aug-29-25 12:24PM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
09:47AM	Here's Why You Should Add CLOV Stock to Your Portfolio Now (Zacks)
09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
08:06AM	Loading…
08:06AM	The Role of M&A in Hologic's Growth Story: Are More Deals in Sight? (Zacks)
07:00AM	Is your AI bet too big? How to balance with other growth themes (Yahoo Finance Video)
Aug-28-25 10:24AM	VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up (Zacks)
08:50AM	DGX Stock Gains Following a New Joint Venture With Corewell Health (Zacks)
08:49AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio? (Zacks)
08:14AM	PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down (Zacks)
08:11AM	Should You Add Zimmer Biomet Stock to Your Portfolio Now? (Zacks)
Aug-27-25 12:25PM	PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment (Zacks)
08:40AM	What's Driving Abbott's Gross Margin Growth Amid Macro Issues (Zacks)
08:31AM	Should You Add IDEXX Stock to Your Portfolio Right Now? (Zacks)
08:29AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
Aug-26-25 08:25AM	Is it the Right Time to Hold Labcorp Stock in Your Portfolio? (Zacks)
Aug-25-25 06:33PM	3 Biotech Catalysts Present Major Opportunity (MarketBeat)
02:26PM	8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It. (Barrons.com)
12:52PM	Natera Shares Rise on the Launch of AI Platform for Precision Oncology (Zacks)
08:47AM	IDEXX Gains 56.2% in a Year: What's Driving the Rally? (Zacks)
08:31AM	HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow? (Zacks)
Aug-24-25 11:27PM	Boston Scientific recalls carotid stents over manufacturing defect (MedTech Dive)
Aug-23-25 08:02AM	Uber Leads 5 Stocks Near Buy Points As Market Rebounds (Investor's Business Daily)
Aug-22-25 04:27PM	Stock Market Week Ahead: Nvidia, Dollar Stores And Canada's Big 5 Banks (Investor's Business Daily)
01:30PM	BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care (Zacks)
11:30AM	Boston Scientific (BSX) Down 0.9% Since Last Earnings Report: Can It Rebound? (Zacks)
09:55AM	Should Boston Scientific Stock Be in Your Portfolio Right Now? (Zacks)
09:55AM	Insulet Gains 77.2% in a Year: What's Driving the Rally? (Zacks)
08:02AM	4 Medical Devices Behemoths to Buy Amid Extensive AI Applications (Zacks)
Aug-21-25 01:33PM	Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market (Zacks)
01:30PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
11:15AM	Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth (Insider Monkey)
10:14AM	Should Quest Diagnostics Stock Be in Your Portfolio Right Now? (Zacks)
10:12AM	Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges (Zacks)
09:50AM	Teleflex Stock Gains Following Barrigel's Launch in Japan (Zacks)
Aug-20-25 01:24PM	Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring (Zacks)
01:11PM	IBD Stock Of The Day Boston Scientific Breaks Out - Here's Why (Investor's Business Daily)
01:05PM	IBD Stock Of The Day Boston Scientific Flashing Early Buy Signal (Investor's Business Daily)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
11:20AM	GEHC Positioned for Growth With AI, Global Expansion and Margins (Zacks)
08:54AM	PAHC Stock Up 76.4% in a Year: What's Driving the Rally? (Zacks)
Aug-19-25 10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
09:48AM	MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up (Zacks)
08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
08:05AM	Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up (Zacks)
Aug-18-25 09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
Aug-15-25 09:43PM	Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT (Insider Monkey)
02:51AM	FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads (Insider Monkey)
12:03AM	2 Reasons to Like BSX (and 1 Not So Much) (StockStory)
Aug-14-25 04:05PM	Elutia Delivers Robust Growth on the Strength of EluPro Market Adoption (GlobeNewswire)
11:17AM	Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
11:05AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
06:32AM	Boston Scientific Watchman device procedure risk (Medical Device Network)
Aug-13-25 12:58PM	RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
08:37AM	MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy? (Zacks)
08:22AM	Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
Aug-12-25 04:27PM	Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run? (Investor's Business Daily)
04:25PM	Boston Scientific At The Starting Line Again After Its Stock Hits A Record High, Consolidates. (Investor's Business Daily)
01:02PM	SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts (Zacks)
12:45PM	3 Reasons Growth Investors Will Love Boston Scientific (BSX) (Zacks)
11:41AM	Reasons to Add Veeva Systems Stock to Your Portfolio for Now (Zacks)
10:37AM	CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls (Zacks)
08:27AM	EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up (Zacks)
08:25AM	Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise (Zacks)
08:14AM	J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue? (Zacks)
04:42AM	US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 \| Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD (GlobeNewswire)
Aug-11-25 10:02AM	SetPoint Medical secures $140M to fund neuromodulation for arthritis (MedTech Dive)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:27AM	Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract (Zacks)
Aug-08-25 04:38PM	Top Stock Reports for JPMorgan Chase, Chevron & Shopify (Zacks)
01:17PM	The Stock Market Gains Despite Noisy Week. Call It Complacency-or the Right Thing to Do. (Barrons.com)
12:24PM	Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue (Benzinga)
12:11PM	Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '25	Option Exercise	0.00	4,243	0	249,833	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '25	Option Exercise	0.00	4,362	0	247,700	Feb 18 05:50 PM
JOHN B SORENSON	Officer	Feb 18 '25	Proposed Sale	104.41	2,657	277,417		Feb 18 04:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience